Glembatumumab vedotin

Phase II Trial In Advanced Breast Cancer ^ NCI Drug Dictionary: Glembatumumab vedotin ^ Pereira, DS; Guevara, CI; Jin, L; Mbong, N; Verlinsky, A; Hsu

int/medicines/services/inn/INN_2008_list60.pdf 2010年6月8日閲覧。.  ^ “Drug Dictionary: Glembatumumab vedotin”. National Cancer Institute. 2018年3月3日閲覧。 ^ a b “ATC/DDD Classification

1038/nbt0511-373. PMID 21552220.  ^ 臨床試験番号 NCT01997333 研究名 "Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple